Obesity & T2D 360° Updates in the Management of Chronic Weight and Type 2 Diabetes
Overview
Communicate Mounjaro value proposition and its use in day-to-day practice for people with type 2 Diabetes and Obesity.
This Activity for
- Clinical Nutrition
- Nursing and Midwifery
- Resident / Fellow
- Physician
- Pharmacy
- Clinical Pharmacy
What I will learn?
•Develop personalized treatment plans for complex cases involving co-morbid T2D and obesity, incorporating both lifestyle and pharmacological strategies.
•Apply evidence-based criteria to select appropriate pharmacologic interventions for patients with T2D and obesity based on individual clinical profiles.
• Illustrate how to incorporate new therapeutic agents into the management and treatment plan of obesity and chronic weight issues, particularly in patients with type 2 diabetes.
•Explain the available strategies of how to manage the side effects of new emerging therapeutic agent during the dose-escalation period
• Interpret the latest updated guidelines and recommendations concerning the new emerging therapeutic agents that are indicated for regulating blood glucose and managing weight, specifically for patients with type 2 diabetes.
• Describe the unique mechanism of action and dual benefits of GIP/GLP-1 receptor agonists in regulating blood glucose and managing weight, specifically for patients with type 2 diabetes.
• Interpret the recent clinical data that supports the use of GIP/GLP-1 receptor agonists in treatment of type 2 diabetes especially in overweight patients
About Organizer
- Virtual Medical Academy
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
| Obesity & T2D 360° Updates in the Management of Chronic Weight and Type 2 Diabetes | Certificate | Free |